Kim E. Goldstein,Robert H. Pietrzak,Katelyn N. Challman,King-Wai Chu,Kevin D. Beck,Lisa A. Brenner,Alejandro Interian,Catherine E. Myers,Keith M. Shafritz,Philip R. Szeszko,Marianne Goodman,M. Mehmet Haznedar,Erin A. Hazlett
The suicide rate for United States military veterans is 1.5× higher than that of non-veterans. To meaningfully advance suicide prevention efforts, research is needed to delineate factors that differentiate veterans with suicide attempt/s, particularly in high-risk groups, e.g., major depressive disorder (MDD), from those with suicidal ideation (no history of attempt/s). The current study aimed to identify clinical, neurocognitive, and neuroimaging variables that differentiate suicide-severity groups in veterans with MDD.